Immunohistochemistry (IHC) Market to Grow at a CAGR of 10.2% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Immunohistochemistry (IHC) Market?

The domain of immunohistochemistry (ihc) has witnessed substantial market expansion recently, projected to escalate from a valuation of $2.58 billion in 2024 to $2.76 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%; this upward trajectory over the past period stems from factors such as increased clinical utilization, the establishment of industry norms, burgeoning cancer investigation efforts, the automation of laboratory procedures, and progress within clinical diagnostic techniques.

Projections indicate that the immunohistochemistry (IHC) sector is poised for substantial expansion during the coming years, reaching a valuation of $4.07 billion by 2029, propelled by a compound annual growth rate (CAGR) of 10.2%.This upward trajectory across the anticipated period is fueled by several factors, including the introduction of novel competitors, increasing requirements within pharmaceutical development pipelines, the incorporation of the technology into biomedical investigations, its expanding utility in diagnostic procedures, and advancements in automation and digital transformation.Key developments expected to shape the market throughout this timeframe encompass the adoption of systems utilizing multiplex IHC methodologies, the merging of IHC workflows with digital pathology platforms, improvements in how specifically antibodies bind their targets, widespread implementation of automated and consistent procedures, and the growing use of IHC in identifying crucial biological markers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Which Drivers Are Supporting Growth Of The Immunohistochemistry (IHC) Market?

The growing incidence of long-term ailments, defined as health issues persisting for a minimum of three months that are manageable but typically not curable, is anticipated to be a primary catalyst for expansion within the immunohistochemistry (IHC) market. IHC is instrumental in identifying these protracted conditions, including malignancies and heart-related problems, by leveraging inherent benefits such as high precision, acute detection capability for specific antigens, and swift diagnostic outcomes. Illustratively, within the United States in 2022, the Centers for Disease Control and Prevention reported that approximately 37.3 million inhabitants were living with diabetes, representing 11.3 percent of the nation’s total population. Consequently, the rising frequency of these persistent health conditions serves as a major impetus fueling the upward trajectory of the immunohistochemistry (IHC) marketplace.

How Is The Immunohistochemistry (IHC) Market Classified Into Different Segments?

The immunohistochemistry (ihc)market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Which Ongoing Trends Are Expected To Shape The Immunohistochemistry (IHC) Market Outlook?

Key players within the immunohistochemistry (IHC) sector are directing their efforts toward refining diagnostic precision by incorporating cutting-edge technologies and superior-grade chemical agents to boost the efficacy of examining biological tissues across a spectrum of medical and research settings. The sophisticated Neoflex multiomics mass spectrometry imaging (MSI) platform provides researchers with a tool for exacting tissue examination, facilitating the progression from initial findings to practical clinical utility by employing high-definition mass spectrometry methods, especially for geographically pinpointing molecular components within tissue structures. To illustrate this, in the month of June 2024, the US entity Bruker Corporation, known for producing scientific instrumentation alongside analytical and diagnostic systems, introduced its MALDI-TOF/TOF Neoflex Imaging Profiler, specifically engineered for tissue visualization via mass spectrometry; this Neoflex MSI apparatus fulfills the requirement for elevating tissue study from the initial imaging phase toward clinical relevance, boasting Bruker’s 10-kHz smartbeam 3D laser, upgraded imaging sensors, and compatibility with the SCiLS Scope software suite for OME-TIFF file creation.

Which Industry Leaders Are Driving Innovation Across The Immunohistochemistry (IHC) Market?

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Which Regional Markets Are Contributing Most To The Immunohistochemistry (IHC) Industry Expansion?

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunohistochemistry (IHC) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795